Nolan Capital
Signal active
Investment Firm
Overview
Nolan Capital is a real estate and other investments company located in Hermosa Beach.
Highlights
Founded
2014
Industry
Financial Services
Employees
1-10
Investment
6
Lead Investment
1
Exits
1
Stages
Late Stage Venture, Early Stage Venture, Seed
Investor Type
Private Equity Firm, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Nolan Capital, established in 2014 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed investments across Financial Services, Venture Capital, Biotechnology, Life Science, Health Care, Genetics, Product Research, Finance, Banking, Impact Investing. The organization boasts a portfolio of 6 investments, with an average round size of $80.3M and 1 successful exits. Their recent investments include BioAdvance, Biotechnology Value Fund, Petrichor Healthcare Capital Management, Jaguar Gene Therapy, Goldman Sachs. The highest investment round they participated in was $53.3B. Among their most notable exits are BioAdvance and Biotechnology Value Fund. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Nolan Capital has made 6 investments. Their most recent investment was on Apr 13, 2021, when Jaguar Gene Therapy raised $139.0M.
Nolan Capital has made 1 diversity investments. Their most recent diversity investment was on Jul 22, 2020, when Encoded Therapeutics raised $135.0M.
investments
6
Diversity investments
1
Lead investments
1
Number of exits
1
Investments
6
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 22, 2020 | Encoded Therapeutics | Biotechnology | 135.0M |
| Aug 05, 2020 | Taysha Gene Therapies | Biotechnology | 95.0M |
| Apr 13, 2021 | Jaguar Gene Therapy | Biotechnology | 139.0M |
| Jan 05, 2023 | - | - | 37.7M |
Exits
1
Funding Timeline
Funding rounds
6
Investors
0
Funds
0
Funding Rounds
6
Nolan Capital has raised 6 rounds. Their latest funding was raised on Jan 05, 2023 from a Series D - Palvella Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 22, 2020 | Series D - Encoded Therapeutics | - | 135.0M | - |
| Aug 05, 2020 | Series B - Taysha Gene Therapies | - | 95.0M | - |
| Apr 13, 2021 | Series B - Jaguar Gene Therapy | - | 139.0M | - |
| Jan 05, 2023 | Series D - Palvella Therapeutics | - | 37.7M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.